Biotechnologies Assets SA (BST.MC)

EUR 0.32

(3.19%)

Total Assets Summary of Biotechnologies Assets SA

  • Biotechnologies Assets SA's latest annual total assets in 2023 was 16.6 Million EUR , down -10.11% from previous year.
  • Biotechnologies Assets SA's latest quarterly total assets in 2023 FY was 16.6 Million EUR , down -10.11% from previous quarter.
  • Biotechnologies Assets SA reported annual total assets of 18.47 Million EUR in 2022, down -7.05% from previous year.
  • Biotechnologies Assets SA reported annual total assets of 19.87 Million EUR in 2021, down -1.66% from previous year.
  • Biotechnologies Assets SA reported quarterly total assets of 16.6 Million EUR for 2023 Q4, up 0.0% from previous quarter.
  • Biotechnologies Assets SA reported quarterly total assets of 17.3 Million EUR for 2023 Q1, down -6.34% from previous quarter.

Annual Total Assets Chart of Biotechnologies Assets SA (2023 - 2010)

Historical Annual Total Assets of Biotechnologies Assets SA (2023 - 2010)

Year Total Assets Total Assets Growth
2023 16.6 Million EUR -10.11%
2022 18.47 Million EUR -7.05%
2021 19.87 Million EUR -1.66%
2020 20.21 Million EUR -78.19%
2019 92.66 Million EUR 16.95%
2018 79.23 Million EUR 350.63%
2017 17.58 Million EUR 10.09%
2016 15.97 Million EUR 7.93%
2015 14.79 Million EUR 0.79%
2014 14.68 Million EUR 58.79%
2013 9.24 Million EUR 21.46%
2012 7.61 Million EUR 4.37%
2011 7.29 Million EUR 45.03%
2010 5.02 Million EUR 0.0%

Peer Total Assets Comparison of Biotechnologies Assets SA

Name Total Assets Total Assets Difference
Atrys Health, S.A. 629 Million EUR 97.36%
Oryzon Genomics S.A. 106.9 Million EUR 84.465%
Pharma Mar, S.A. 341.22 Million EUR 95.133%
Laboratorios Farmaceuticos Rovi, S.A. 799.88 Million EUR 97.924%